BofA Securities Downgrades Amphastar Pharmaceuticals (AMPH) to Underperform
Tweet Send to a Friend
(Updated - June 29, 2026 6:14 AM EDT)
BofA Securities analyst Jason Gerberry downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Gerberry downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
